A Multi-center, Placebo-controlled Study to Evaluate the Safety of GSK716155 and Its Effects on Myocardial Metabolism, Myocardial Function, and Exercise Capacity in Patients With NYHA Class II/III Congestive Heart Failure
This study has been completed.
First Posted: May 23, 2011
Last Update Posted: August 17, 2017
Information provided by (Responsible Party):